New Insight and Old Wisdom in the Diagnosis and Prognostication of Pancreatic Cysts
Dr. Koushik Das covers the past, present, and future of pancreatic cyst diagnosis. Review the role of first-line diagnostic testing in the prediction of pancreatic cyst pathology. Learn about recent advances and limitations in molecular diagnostic testing and Next Generation Sequencing for mucinous cyst risk stratification.
Interpace, Interpace biosciences, pancreas, pancreatic cysts, pancreatic cancer, biomarkers, diagnostic testing, molecular diagnostic testing, mucinous cyst risk stratification, Koushik Das, Dr Das, Dr. Das, Dr. Koushik Das, Dr Koushik Das, dna sequencing, dna of pancreatic cysts, CEA, glycoprotein, cyst fluid, TTNFB, telomerase, Sanger sequencing, UMI, NGS panel, genomics of pancreatic cysts, next generation sequencing
Other Featured Videos
Clinical Practice Model - PillSense™ Diagnostic Capsule for Upper Gastrointestinal Bleeding Triage and Management
April 14, 2026
ENow Solutions
A team of key opinion leaders presents a clinical practice model of PillSense™, a single-use, disposable device, that detects blood in the upper GI tract with high sensitivity and predictive value. Challenges, potential benefits, and integration of PillSense™ are considered and its use as a tool to triage patients, potentially reducing unnecessary admissions and procedures. The KOLs close with future directions of upper gastrointestinal bleeding management and an extensive Q&A discussion.
Clinical Algorithm and Tools for Complex Biliary Stone Management
November 20, 2024
Olympus
Dr. Haber and Dr. Das utilize clinical cases to review a clinical approach/algorithm for managing difficult bile duct stones. These experts review the endoscopic tools available for the management of biliary stones and discuss the pathogenesis and diagnostic workup of biliary diseases.
Optimizing Endobariatric Care: From Patient Selection to Long-Term Outcomes
October 7, 2026
Boston Scientific EDUCARE
Dr. Geri Keane and nurse practitioner Kristen Koller work through how to build an endobariatric program, from patient intake and ESG eligibility screening to insurance authorization, procedure preparation, recovery, and follow-up. The speakers emphasize setting realistic expectations, screening for behavioral and medical concerns, and coordinating care across clinicians, dietitians, behavioral health, and administrative staff. They review evidence for durable weight loss after ESG and highlight frequent follow-up, accessible referral pathways, and regular process reviews as keys to patient and program success.
